Ittai Dev Disposes 33,320 MDB Shares via Pre-Set Trading Plan
Rhea-AI Filing Summary
Insider stock sales by MongoDB CEO and director Ittai (Ittycheria) Dev on 08/28/2025 totaled 33,320 Class A shares sold under a Rule 10b5-1 plan. The filings list multiple block sales at weighted-average prices from about $297.83 up to $310.17, with per-tranche price ranges disclosed in footnotes. Following these disposals, the reporting person beneficially owned 203,237 Class A shares. The Form 4 was signed by an attorney-in-fact on 09/02/2025 and confirms the trades were made pursuant to a pre-established trading plan rather than ad hoc transactions.
Positive
- Transactions executed under a Rule 10b5-1 plan, indicating pre-established trading instructions
- Detailed price ranges and weighted-average prices provided for transparency
- Timely Form 4 filing signed by attorney-in-fact on 09/02/2025
Negative
- Insider sold 33,320 Class A shares, reducing beneficial ownership to 203,237 shares
Insights
TL;DR: CEO/director sold 33,320 Class A shares via a Rule 10b5-1 plan, leaving 203,237 shares held.
The reported transactions are routine executive liquidity under a documented Rule 10b5-1 plan, reducing beneficial ownership from earlier levels to 203,237 Class A shares. Sales occurred in multiple tranches at weighted-average prices reported per tranche between $297.83 and $310.17, with detailed price ranges disclosed in footnotes. There is no indication in this Form 4 of options exercised, purchases, or derivative transactions—only non-derivative sales. For investors, this filing documents insider selling but attributes it to a pre-established plan, which typically reduces the likelihood the trades reflect new private information.
TL;DR: Sales executed under a 10b5-1 plan, signed by attorney-in-fact; procedural compliance appears met.
The Form 4 identifies the reporting person as both President & CEO and a director, and explicitly checks the box indicating the transactions were executed pursuant to a Rule 10b5-1 trading plan. The filing includes weighted-average prices and per-tranche ranges for transparency and is signed by an attorney-in-fact on 09/02/2025. From a governance perspective, use of a documented 10b5-1 plan and timely disclosure aligns with standard insider-trading compliance practices. The filing does not present material corporate governance concerns by itself.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 425 | $297.83 | $127K |
| Sale | Class A Common Stock | 200 | $298.86 | $60K |
| Sale | Class A Common Stock | 26,020 | $299.99 | $7.81M |
| Sale | Class A Common Stock | 721 | $301.04 | $217K |
| Sale | Class A Common Stock | 411 | $302.30 | $124K |
| Sale | Class A Common Stock | 200 | $303.20 | $61K |
| Sale | Class A Common Stock | 300 | $304.50 | $91K |
| Sale | Class A Common Stock | 900 | $305.91 | $275K |
| Sale | Class A Common Stock | 550 | $307.08 | $169K |
| Sale | Class A Common Stock | 2,350 | $308.35 | $725K |
| Sale | Class A Common Stock | 1,043 | $309.31 | $323K |
| Sale | Class A Common Stock | 200 | $310.17 | $62K |
Footnotes (1)
- The transaction was pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $297.24 to $298.13, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $298.37 to $299.35, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $299.50 to $300.33, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $300.75 to $301.50, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $301.89 to $302.50, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $303.11 to $303.28, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $304.37 to $304.77, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $305.44 to $306.25, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $306.50 to $307.36, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $307.87 to $308.80, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $308.94 to $309.88, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $309.96 to $310.37, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
FAQ
What did MongoDB insider Ittai Dev sell on 08/28/2025?
Were these sales ad hoc or part of a trading plan?
Who signed the Form 4 and when was it filed?